Company Snapshot: MKG  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Mallinckrodt Directors Declare Quarterly Dividend

    ST. LOUIS, Aug. 22 /PRNewswire/ -- The board of directors of Mallinckrodt
Inc. (NYSE: MKG) has declared a quarterly dividend of 16.5 cents per share on
the company's common stock, payable September 30, 2000, to shareholders of
record at the close of business on September 15, 2000.
    At its August meeting, the board also declared the regular $1 per share
quarterly dividend on Mallinckrodt's 4 percent cumulative preferred stock,
also payable September 30, 2000, to shareholders of record at the close of
business on September 15, 2000.
    Mallinckrodt Inc. is a global manufacturer and marketer of specialty
medical products designed to sustain breathing, diagnose disease and relieve
pain.  Named one of America's most admired medical products and equipment
companies by Fortune magazine, Mallinckrodt does business in more than 100
countries.  In fiscal 1999, combined net sales were $2.6 billion for
Mallinckrodt's respiratory, imaging and pharmaceutical product lines.  Based
in St. Louis, Missouri, Mallinckrodt's website address is
http://www.mallinckrodt.com .
    Contact:  Media, Barbara Abbett, 314-654-5230, email,
barbara.abbett@mkg.com, or Investors, Robert Martsching, 314-654-3190, email,
Invest@mkg.com, both of Mallinckrodt, Inc.


SOURCE Mallinckrodt Inc.




Back to Topback to top

Related links:
  • http://www.mallinckrodt.com
    Company News On-Call:
  • http://www.prnewswire.com/comp/440950.html or fax,
    800-758-5804, ext. 440950
    CONTACT:
    Media, Barbara Abbett, 314-654-5230, email,
    barbara.abbett@mkg.com, or Investors, Robert Martsching,
    314-654-3190, email, Invest@mkg.com, both of Mallinckrodt, Inc.